Clover Health Investments (BSP:CLOV34) Forward Dividend Yield %: 0.00% (As of Jun. 24, 2026)


BSP:CLOV34 Clover Health Investments Corp BSP:CLOV34
48 GF Score
Price R$26.19
GF Value R$20.49
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Clover Health Investments Forward Dividend Yield %?

Clover Health Investments BSP:CLOV34 48 Forward Dividend Yield % is 0.00% as of Jun. 24, 2026. GuruFocus rates BSP:CLOV34 with a GF Score™ of 48/100 and a GF Value™ of R$20.49 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 9 Healthcare Plans companies, Clover Health Investments ranks worse than 11111100% on this metric.

As of today (2026-06-24), the Forward Annual Dividend Yield of Clover Health Investments is 0.00%.

As of today (2026-06-24), the Trailing Annual Dividend Yield of Clover Health Investments is 0.00%.

BSP:CLOV34's Forward Dividend Yield % is not ranked *
in the Healthcare Plans industry.
Industry Median: 2.21
* Ranked among companies with meaningful Forward Dividend Yield % only.

Clover Health Investments's Dividends per Share for the three months ended in Mar. 2026 was R$0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Clover Health Investments  (BSP:CLOV34) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Clover Health Investments Forward Dividend Yield % Related Terms


BSP:CLOV34 vs PGNY, ALHC, PFHO: Forward Dividend Yield % Comparison

For the Healthcare Plans subindustry, Clover Health Investments's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Clover Health Investments Forward Dividend Yield % vs Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, Clover Health Investments's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Clover Health Investments's Forward Dividend Yield % falls into.


BSP:CLOV34
48GF Score
Clover Health Investments Corp BSP:CLOV34
Forward Dividend Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Clover Health Investments Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

What does a Forward Dividend Yield % of 0.00% mean?
Clover Health Investments (BSP:CLOV34) has a Forward Dividend Yield % of 0.00% as of Jun. 24, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Clover Health Investments and its competitors. According to the industry distribution chart, Clover Health Investments ranks #999999 out of 9 companies in the Healthcare Plans industry.
Is Clover Health Investments' Forward Dividend Yield % too high?
Clover Health Investments' current Forward Dividend Yield % is 0.00%. Based on the distribution chart, Clover Health Investments ranks #999999 out of 9 companies in the Healthcare Plans industry, which is in the bottom quartile relative to peers. Overall, Clover Health Investments has a GF Score™ of 48/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Clover Health Investments' Forward Dividend Yield % compare to PGNY and ALHC?
According to the Healthcare Plans industry distribution chart, Clover Health Investments ranks #999999 out of 9 companies for Forward Dividend Yield %. This places Clover Health Investments in the lower half of its industry. The industry median Forward Dividend Yield % is 2.21. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Healthcare Plans company?
The median Forward Dividend Yield % among Healthcare Plans companies is 2.21, based on 9 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Clover Health Investments and its competitors. For the Healthcare Plans industry, the median Forward Dividend Yield % is 2.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Clover Health Investments's current Forward Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clover Health Investments stock overvalued right now?
Based on GuruFocus' analysis, Clover Health Investments (BSP:CLOV34) is currently considered Modestly Overvalued. The stock's GF Value™ is R$20.49, compared to a current price of R$26.19 — trading 27.8% above its estimated fair value. The current Forward Dividend Yield % is 0.00%. Clover Health Investments' overall GF Score™ is 48/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Clover Health Investments (BSP:CLOV34), the current Forward Dividend Yield % is 0.00% as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Clover Health Investments (BSP:CLOV34) Overvalued in 2026?

Based on GuruFocus' analysis, Clover Health Investments stock appears to be overvalued. The current stock price of R$26.19 is trading 27.8% above its estimated GF Value™ of R$20.49. GuruFocus considers Clover Health Investments to be Modestly Overvalued.

Key valuation signals for BSP:CLOV34:

  • Forward Dividend Yield %: 0.00%
  • GF Value™: R$20.49 vs. price of R$26.19 (27.8% above fair value)
  • GF Score™: 48/100 with 5 warning signs

No single metric tells the full story. See the BSP:CLOV34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Clover Health Investments Business Description

Other Exchanges CLOV:USA7QD:Germany
Address 3401 Mallory Lane, Suite 210, Franklin, TN, USA, 37067
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.
48GF Score

Get the complete analysis for BSP:CLOV34

Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$26.19
Price
R$20.49
GF Value